HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers.

Abstract
The field safety and efficacy of a bivalent Marek's disease (MD) vaccine (herpesvirus of turkeys + strain SB-1) administered in ovo were evaluated. The vaccine was administered to commercial broiler chicken eggs using Embrex's INOVOJECT automated egg-injection system. Comparisons were made with a conventional method of vaccination, in which the vaccine was administered subcutaneously to chicks at hatching. In ovo administration of the vaccine at day 17.5-18.5 of incubation significantly reduced the number of culled chicks, early mortality, and overall mortality during the grow-out period compared with conventional vaccination. However, hatchability was significantly lower in in ovo-treated chicks. Overall livability and feed efficiency were higher in the in ovo-treated chicks than in conventionally vaccinated chicks. Total field-caused condemnations and condemnations due to airsacculitis and septicemia/toxemia were also lower in the in ovo-vaccinated chicks. No difference in the leukosis (MD) condemnation rate was observed between the two treatment groups. In ovo vaccination provided 93.25% protection against challenge with a very virulent strain of MD virus (strain RB1/B); by comparison, the conventional vaccination method provided 89.58% protection.
AuthorsG Sarma, W Greer, R P Gildersleeve, D L Murray, A M Miles
JournalAvian diseases (Avian Dis) 1995 Apr-Jun Vol. 39 Issue 2 Pg. 211-7 ISSN: 0005-2086 [Print] UNITED STATES
PMID7677641 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Viral Vaccines
Topics
  • Animals
  • Body Weight
  • Chick Embryo
  • Chickens (growth & development)
  • Drug Administration Schedule
  • Energy Metabolism
  • Marek Disease (prevention & control)
  • Safety
  • Vaccination (methods, veterinary)
  • Viral Vaccines (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: